MedPath

Cortical Excitability and Role of rTMS in Cannabis Use Disorder

Early Phase 1
Conditions
Cannabis Use Disorder, Moderate
Registration Number
NCT04106336
Lead Sponsor
Assiut University
Brief Summary

Repetitive transcranial magnetic stimulation (rTMS) and cortical excitability have a role in cannabis use disorder

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
60
Inclusion Criteria
  • 18to 50 years of age
  • cannabis use disorder according to DSM 5 definition
  • clear consent to participate in study
Exclusion Criteria
  • cardiac peacemaker
  • metal implant in the head as participate will be applied to magnetic field of TMS
  • current intake of any medication affect cognition (as anti psychotic and anti epileptic)
  • current history of neurological , psychiatric or general medical disease .current or previous drug (other than cannabis )or alcohol abuse or participation in another trial during the past 8 weeks .
  • age younger than 18 and older than 50 years

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Determination of role of rTMS for reducing cannabis craving1 year

Incidenc of cannabis craving after rTMS

Secondary Outcome Measures
NameTimeMethod
Estimation of cortical excitability in cannabis addict1 year

Incidence of cannabis craving after cortical excitability

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.